Wide-field retinal imaging in the management of noninfectious posterior uveitis.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 22935598)

Published in Am J Ophthalmol on August 28, 2012

Authors

John Peter Campbell1, Henry Alexander Leder, Yasir Jamal Sepah, Theresa Gan, James P Dunn, Elham Hatef, Brian Cho, Mohamed Ibrahim, Millena Bittencourt, Roomasa Channa, Diana V Do, Quan Dong Nguyen

Author Affiliations

1: Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.

Articles citing this

Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion. Results of a proof of concept study. Graefes Arch Clin Exp Ophthalmol (2014) 1.07

A comprehensive review of diagnostic imaging technologies to evaluate the retina and the optic disk. Int Ophthalmol (2015) 0.80

Choroidal Vascularity Index (CVI) - A Novel Optical Coherence Tomography Parameter for Monitoring Patients with Panuveitis? PLoS One (2016) 0.78

Retinal imaging in uveitis. Saudi J Ophthalmol (2014) 0.78

Comparison of wide-field fluorescein angiography and 9-field montage angiography in uveitis. Am J Ophthalmol (2013) 0.78

A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol (2014) 0.77

Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity. Ophthalmology (2015) 0.77

Update on wide- and ultra-widefield retinal imaging. Indian J Ophthalmol (2015) 0.76

Risk of Retinal Neovascularization in Cases of Uveitis. Ophthalmology (2015) 0.76

A prospective, observational study on the application of ultra-wide-field angiography in the evaluation and management of patients with anterior uveitis. PLoS One (2015) 0.76

Ultra-Wide-Field Fluorescein Angiography in Microscopic Polyangiitis. Case Rep Ophthalmol Med (2016) 0.75

Assessment of vitreous haze using ultra-wide field retinal imaging. J Ophthalmic Inflamm Infect (2016) 0.75

Ultra-wide field angiography in the management of Eales disease. Indian J Ophthalmol (2016) 0.75

Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup. Case Reports Immunol (2014) 0.75

Articles by these authors

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology (2012) 8.29

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA (2003) 5.33

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2010) 3.49

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology (2013) 2.99

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2009) 2.77

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther (2008) 2.59

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther (2006) 2.59

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol (2006) 2.50

In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23

Evaluation of patients with scleritis for systemic disease. Ophthalmology (2004) 2.22

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology (2012) 2.20

Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02

Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants. Ophthalmology (2012) 1.95

Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study. J Ophthalmic Inflamm Infect (2013) 1.85

Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology (2005) 1.80

Recent trends in the management of rhegmatogenous retinal detachment. Surv Ophthalmol (2008) 1.78

Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol (2007) 1.66

Endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal thinning (edict) syndrome maps to chromosome 15q22.1-q25.3. Am J Ophthalmol (2002) 1.56

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol (2013) 1.55

Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina (2010) 1.54

Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology (2010) 1.54

Encephalitis and myelitis associated with dengue viral infection clinical and neuroimaging features. Clin Neurol Neurosurg (2008) 1.53

Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51

Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology (2008) 1.46

Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology (2005) 1.46

PharmD in Pakistan: a tag or a degree? Am J Pharm Educ (2009) 1.46

Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema. Invest Ophthalmol Vis Sci (2014) 1.45

Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology (2006) 1.45

Persistent diabetic macular edema is associated with elevated hemoglobin A1c. Am J Ophthalmol (2005) 1.43

Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol (2006) 1.43

Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. Diabetes Technol Ther (2006) 1.40

Blood pressure control for diabetic retinopathy. Sao Paulo Med J (2015) 1.40

New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence. Acta Ophthalmol Scand (2007) 1.40

Correspondence. Retina (2016) 1.38

Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36

The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology (2011) 1.34

Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina (2007) 1.34

Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages. J Diabetes Sci Technol (2011) 1.33

Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol (2005) 1.31

RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol (2010) 1.27

Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging (2009) 1.25

DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer. Cell (2011) 1.25

Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly. Cancer Res (2002) 1.20

Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology (2011) 1.18

Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol (2003) 1.18

Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol (2010) 1.14

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology (2010) 1.13

A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology (2009) 1.13

Monitoring ocular drug therapy by analysis of aqueous samples. Ophthalmology (2009) 1.12

The Persian Wednesday Eve Festival "Charshanbe-Soori" fireworks eye injuries: a case series. Ophthalmic Epidemiol (2007) 1.11

Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol (2005) 1.11

Acute posterior multifocal placoid pigment epitheliopathy associated with a systemic necrotizing vasculitis. Retina (2003) 1.10

Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis (2003) 1.09

Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol (2009) 1.08

Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol (2007) 1.08

Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol (2008) 1.07

Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect (2012) 1.07

Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07

Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity. Middle East Afr J Ophthalmol (2010) 1.03

Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol (2008) 1.03

Blood-induced interference of glucose sensor function in vitro: implications for in vivo sensor function. J Diabetes Sci Technol (2007) 1.02

Measurement of oxygen saturation in the retina with a spectroscopic sensitive multi aperture camera. Opt Express (2008) 1.02

Retinal optical coherence tomography manifestations of intraocular lymphoma. J Ophthalmic Inflamm Infect (2012) 1.01

Changing patterns and outcome of Dengue infection; report from a tertiary care hospital in Pakistan. J Pak Med Assoc (2008) 1.01

Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant. Am J Ophthalmol (2012) 1.01

Maintenance of open chromatin and selective genomic occupancy at the cell cycle-regulated histone H4 promoter during differentiation of HL-60 promyelocytic leukemia cells. Mol Cell Biol (2003) 1.01

Management of retained subretinal perfluorocarbon liquid. Ophthalmic Surg Lasers Imaging Retina (2013) 0.99

A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina (2008) 0.99

Breast cancer in malaysia: are our women getting the right message? 10 year-experience in a single institution in Malaysia. Asian Pac J Cancer Prev (2007) 0.99

Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies. Am J Ophthalmol (2009) 0.98

Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol (2004) 0.97

Retina-simulating phantom for optical coherence tomography. J Biomed Opt (2014) 0.97

A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology (2010) 0.97